Vito Lampasona

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

Viral Diagnostics, Immunodeficiencies, Viral Immunity +19

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Tom Le Voyer et al. · Science Immunology · 2021 · 600 citations · Full text

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo et al. · Nature Communications · 2021 · 373 citations · Full text

Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies

Ezio Bonifacio, Vito Lampasona, Stefano Genovese et al. · The Journal of Immunology · 1995 · 238 citations

Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk

Peter Achenbach, Vito Lampasona, Ulrike Landherr et al. · Diabetologia · 2009 · 197 citations · Full text

Metabolic Syndrome, Diabetes Epidemiology, Autoimmune Disease +8